RHY rhythm biosciences limited

thanks. published 2021 so Deloitte did not yet took note of the...

  1. 27 Posts.
    lightbulb Created with Sketch. 13
    thanks. published 2021 so Deloitte did not yet took note of the trial results for sensitivity and specificity in study 7. it also mentions:

    "In any decision to transition to a new test type, it is important that the test is approved by the Therapeutic Goods Administration (as per the guidance in the NBCSP Quality Framework) and a cost-effectiveness analysis is performed using reliable estimates of test sensitivity and specificity, as compared with the current iFOBT."

    so just waiting news from TGA.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
6.3¢
Change
0.003(5.00%)
Mkt cap ! $17.89M
Open High Low Value Volume
6.0¢ 6.3¢ 6.0¢ $18.34K 301.4K

Buyers (Bids)

No. Vol. Price($)
1 100000 5.8¢
 

Sellers (Offers)

Price($) Vol. No.
6.5¢ 123287 3
View Market Depth
Last trade - 15.57pm 07/07/2025 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.